Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Immunoglobulin for Unverricht-Lundborg Disease: Single-patient Trial.

NCT03351569 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale di Mantova as lead sponsor.

NCT NCT03351569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03351569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Immunoglobulin for Unverricht-Lundborg Disease: Single-patient Trial.
Lead sponsor
Azienda Socio Sanitaria Territoriale di Mantova
Phase
Phase 3
Overall status
Unknown status
Start date
December 9, 2015
Completion date
December 30, 2017
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

unverricht-lundborg disease